EverSource Wealth Advisors’s Wave Life Sciences WVE Stock Holding History

EverSource Wealth Advisors’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.26K	Buy	1,421 +1,003	+240%	+$6.65K	﹤0.01%	3017
2026 Q1	$3.03K	Buy	418 +194	+87%	+$2.53K	﹤0.01%	3489
2025 Q4	$3.81K	Buy	224 +24	+12%	+$244	﹤0.01%	3231
2025 Q3	$1.46K	Sell	200 -2	-1%	-$16	﹤0.01%	3637
2025 Q2	$1.31K	Buy	202 +197	+3,940%	+$1.3K	﹤0.01%	3660
2025 Q1	$40	Buy	+5	New	+$55	﹤0.01%	3918

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

EverSource Wealth Advisors's WVE Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Wave Life Sciences (WVE) stake by 240% in Q2 2026, buying an estimated $6.65K and bringing the position to 1,421 shares worth $8.26K. The position accounts for ﹤0.01% of the portfolio, ranked #3017.

EverSource Wealth Advisors first reported a position in WVE in Q1 2025 and has held it in 6 quarters since. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

EverSource Wealth Advisors held 1,421 shares of Wave Life Sciences worth $8.26K as of Q2 2026.
EverSource Wealth Advisors bought 1,003 Wave Life Sciences shares in Q2 2026, an estimated $6.65K.
Wave Life Sciences made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3017 holding.
EverSource Wealth Advisors first reported a position in Wave Life Sciences in Q1 2025 and has held it in 6 quarters since.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.